Nasdaq stocks posting largest percentage increases
AP - Thu Oct 09, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SSRI: 5.74 (+0.09), BRID: 8.49 (unch), RENT: 73.90 (+3.69), JAXB: 11.20 (+0.45), RDUS: 18.45 (+0.72), DRIV: 16.60 (-0.24), OBCI: 4.09 (-0.40), SSO.TO: 6.46 (+0.06), ACHN: 10.13 (+0.12), AUXL: 30.41 (-0.46), LAKE: 23.60 (+2.17), GTIV: 19.35 (+0.02)
November 28th Options Now Available For Achillion Pharmaceuticals (ACHN)
DividendChannel.com - Thu Oct 09, 10:04AM CDT
Investors in Achillion Pharmaceuticals Inc. saw new options become available today, for the November 28th expiration.
ACHN: 10.13 (+0.12)
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
GlobeNewswire - Wed Oct 08, 9:23AM CDT
- Late breaker poster presentation will feature updated SVR results from the Phase 2 trial of ACH-3102, NS5A inhibitor, plus sofosbuvir for the eight-week treatment of genotype 1 HCV -
ACHN: 10.13 (+0.12)
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma
at The Street - Fri Oct 03, 8:41AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
JNJ: 98.21 (+1.20), SGEN: 33.33 (+1.37), CPRX: 2.44 (+0.07), ACHN: 10.13 (+0.12), SNSS: 1.24 (+0.09), BMY: 48.96 (+0.04)
Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold?
Todd Campbell, The Motley Fool - Motley Fool - Wed Oct 01, 11:37AM CDT
Source: Achillion Pharmaceuticals. Achillion investors are probably shaking their heads wondering what's wrong with their company following Johnson & Johnson 's acquisition of the privately held Alios for $1.7 billion this week. On the...
JNJ: 98.21 (+1.20), GILD: 96.16 (-1.02), ACHN: 10.13 (+0.12)
J&J Buying Alios, Going Up Against Gilead
at Investor's Business Daily - Tue Sep 30, 11:02AM CDT
Medical giant Johnson & Johnson agreed to buy privately held biotech Alios BioPharma for $1.75 billion Tuesday, advancing its presence in viral diseases. Johnson & Johnson (JNJ) stock was up a fraction in morning trading on the stock market today. In...
JNJ: 98.21 (+1.20), VRTX: 101.10 (-3.16), GILD: 96.16 (-1.02), ACHN: 10.13 (+0.12), MRK: 54.73 (-1.60)
Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax
at The Street - Tue Sep 30, 8:49AM CDT
What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?
JNJ: 98.21 (+1.20), VRTX: 101.10 (-3.16), GILD: 96.16 (-1.02), NVAX: 4.69 (+0.20), ACHN: 10.13 (+0.12)
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver
PR Newswire - Tue Sep 30, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, DWA, SUNE, LOCO and WFM.
WFM: 36.92 (-0.14), SUNE: 15.11 (+0.31), ACHN: 10.13 (+0.12), LOCO: 33.57 (-0.71), DWA: 20.83 (-0.25)
The 5 Best Biotech Stocks in 2014...so far
Todd Campbell, The Motley Fool - Motley Fool - Fri Sep 26, 7:35AM CDT
Since the quarter is wrapping up and investors are considering their game plan heading into year-end, let's look at biotech's biggest winners for the year, why they've rallied, and whether they make sense for your portfolio . Specifically, let's...
GILD: 96.16 (-1.02), ACHN: 10.13 (+0.12), RCPT: 62.07 (-1.61), PTCT: 37.07 (+0.17), ICPT: 198.08 (+11.86), PBYI: 215.19 (+8.62)
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma
PR Newswire - Tue Sep 16, 8:05AM CDT
The US markets on Monday, September 15 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,031.14, up 0.26% and the NASDAQ Composite closed at 4,518.90, down 1.07%. The S&P 500 finished the session 0.07% lower at 1,984.13. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 734.33, down 0.32%, whereas the index has gained 6.67% in the previous three months. Investor-Edge has initiated coverage on the following equities: Medivation Inc. (NASDAQ: MDVN), Galectin Therapeutics Inc. (NASDAQ: GALT), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), and PDL BioPharma Inc. (NASDAQ: PDLI). Free research on these five companies can be accessed at:
MDVN: 89.63 (-1.68), IRWD: 13.35 (+0.84), ACHN: 10.13 (+0.12), GALT: 4.88 (+0.11), PDLI: 7.63 (+0.01)
ACHN, IBIO, CRAY, IBCA, QLTY, PIY Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 16, 6:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Ibio Inc (NYSE:IBIO), Cray Inc (NASDAQ:CRAY), Intervest Bancshares Corp (NASDAQ:IBCA), Quality Distribution Inc (NASDAQ:QLTY), Preferredplus Trust Series Czn 1 (NYSE
PIY: 25.55 (-0.39), QLTY: 11.10 (+0.06), ACHN: 10.13 (+0.12), IBIO: 1.39 (-0.01), IBCA: 9.55 (-0.02), CRAY: 25.35 (+0.46)
'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 229.70 (+2.64), XBI: 152.22 (+5.15), IBB: 256.47 (+1.20), JBLU: 10.30 (+0.07), DEO: 109.77 (-0.09), NOK: 7.77 (-0.19), YHOO: 37.82 (-0.15), EBAY: 50.24 (-0.35), PLCE: 48.03 (-0.18), TWTR: 49.99 (+1.41), MSFT: 43.22 (-0.51), AAPL: 97.54 (-1.21), REGN: 334.75 (+6.68), AMZN: 305.97 (-2.34), ABX: 13.55 (-0.12), NADL: 5.54 (-0.31), DRI: 48.24 (+0.11), CELG: 86.55 (+0.07), AA: 14.50 (+0.21), BIDU: 205.73 (+6.66), TSO: 58.64 (-0.58), GILD: 96.16 (-1.02), ACHN: 10.13 (+0.12), IWM: 106.60 (+1.06), BF.B: 83.61 (-1.04), CRM: 53.09 (+0.37)
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver
PR Newswire - Mon Sep 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, LITB, VJET, WFM and DIS.
WFM: 36.92 (-0.14), VJET: 12.61 (-0.06), ACHN: 10.13 (+0.12), DIS: 82.08 (-2.06), LITB: 6.19 (+0.01)
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
at The Street - Thu Sep 11, 6:47PM CDT
As long as it's here, good things are happening every day, Cramer says.
SD: 4.54 (+0.77), RH: 74.98 (+2.35), RAX: 35.04 (+0.28), EMN: 73.47 (+0.65), OKE: 54.48 (+0.77), KORS: 71.42 (-0.73), ATK: 124.00 (-1.05), CNVR: 33.54 (-0.42), SBUX: 72.38 (-0.36), SON: 37.73 (+0.14), ACAD: 25.11 (+2.23), COH: 35.54 (-0.08), FSLR: 53.24 (+1.24), ISIS: 38.97 (+2.13), ACHN: 10.13 (+0.12), JE: 4.34 (-0.18), MTN: 82.13 (-0.99), AIG: 49.69 (-0.38), KATE: 25.30 (-0.14), TWTR: 49.99 (+1.41), TASR: 14.69 (+0.49), SWHC: 9.53 (+0.09)
Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:58AM CDT
Can the Rally in Achillion (ACHN) Shares Continue?
ACHN: 10.13 (+0.12)
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications
PR Newswire - Tue Sep 09, 7:35AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Deere & Company (NYSE: DE), Honeywell International Inc. (NYSE: HON), Lockheed Martin Corporation (NYSE: LMT) and L-3 Communications Holdings Inc. (NYSE: LLL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6311-100free.
LMT: 175.19 (-0.92), HON: 85.11 (-1.08), ACHN: 10.13 (+0.12), DE: 84.93 (+0.57), LLL: 109.09 (+0.82)
Most active Nasdaq-traded stocks
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
EBAY: 50.24 (-0.35), GILD: 96.16 (-1.02), FB: 73.21 (-0.38), ACHN: 10.13 (+0.12), MSFT: 43.22 (-0.51), INTC: 31.27 (-0.87), AAPL: 97.54 (-1.21), CSCO: 22.96 (-0.10)
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
at The Street - Fri Sep 05, 7:55AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
MDVN: 89.63 (-1.68), ECYT: 5.68 (unch), ACHN: 10.13 (+0.12), ARIA: 5.48 (+0.32), EXEL: 1.55 (+0.03)